Filed: 8/14/2024ACC: 0001398344-24-014608
π What this filing means
ESSEX WOODLANDS MANAGEMENT, INC. filed this quarterly 13FβHR report disclosing 7 equity positions with a total reported market value of $306.70M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
7
Positions
$306.70M
Total AUM (reported)
49.53M
Total Shares
Allocation by class
COM$216.74M70.7%
COM CL A$74.87M24.4%
COM NEW$15.09M4.9%
Portfolio Concentration
Top 3$289.59M94.4%
4β10$17.12M5.6%
Top 3 weight
94.4%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 49.53M
Sole
Full voting authority
49.53M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole7
Shared0
Other0
Dominant voting typeSole Β· 100.0% of voting shares
Institutional Holdings7
Rows:
MIMEDX GROUP, INC.
SOLEShares28.20M
TypeSH
Market value$195.39M
63.71%
Sole
28.20M
Shared
0.00
None
0.00
BIOVENTUS
SOLEShares13.02M
TypeSH
Market value$74.87M
24.41%
Sole
13.02M
Shared
0.00
None
0.00
TELA BIO, INC.
SOLEShares4.11M
TypeSH
Market value$19.32M
6.30%
Sole
4.11M
Shared
0.00
None
0.00
EYEPOINT PHARMACEUTICALS INC
SOLEShares1.55M
TypeSH
Market value$13.50M
4.40%
Sole
1.55M
Shared
0.00
None
0.00
MEDICINOVA INC
SOLEShares1.11M
TypeSH
Market value$1.59M
0.52%
Sole
1.11M
Shared
0.00
None
0.00
REVANCE THERAPEUTICS INC
SOLEShares457.08K
TypeSH
Market value$1.17M
0.38%
Sole
457.08K
Shared
0.00
None
0.00
VENUS CONCEPT, INC.
SOLEShares1.09M
TypeSH
Market value$852.8K
0.28%
Sole
1.09M
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting β Sole | Shared | None |
|---|---|---|---|---|---|---|---|
MIMEDX GROUP, INC.SOLE | COM | 28.20M | SH | $195.39M 63.71% | 28.20M | 0.00 | 0.00 |
BIOVENTUSSOLE | COM CL A | 13.02M | SH | $74.87M 24.41% | 13.02M | 0.00 | 0.00 |
TELA BIO, INC.SOLE | COM | 4.11M | SH | $19.32M 6.30% | 4.11M | 0.00 | 0.00 |
EYEPOINT PHARMACEUTICALS INCSOLE | COM NEW | 1.55M | SH | $13.50M 4.40% | 1.55M | 0.00 | 0.00 |
MEDICINOVA INCSOLE | COM NEW | 1.11M | SH | $1.59M 0.52% | 1.11M | 0.00 | 0.00 |
REVANCE THERAPEUTICS INCSOLE | COM | 457.08K | SH | $1.17M 0.38% | 457.08K | 0.00 | 0.00 |
VENUS CONCEPT, INC.SOLE | COM | 1.09M | SH | $852.8K 0.28% | 1.09M | 0.00 | 0.00 |